# MoonLake Immunotherapeutics: Form S-1/A, filed May 2, 2022

- Company: [MoonLake Immunotherapeutics](/companies/mltx.md) (CIK 1821586)
- Form: S-1/A
- Filed: 2022-05-02
- Accepted by EDGAR: May 2, 2022, 16:10 ET
- Period: not reported
- Accession: 0001213900-22-023173
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1821586/000121390022023173/fs12022a3_moonlakeim.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1821586/000121390022023173/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1821586/000121390022023173/fs12022a3_moonlakeim.htm

Filed May 2, 2022.
Source: SEC EDGAR, the filing index for accession 0001213900-22-023173. Last ingested by Listed: Nov 4, 2026, 07:34 ET. No prices; not investment advice.
